Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 238,000 | 248,000 | 192,000 | 150,000 | 201,000 |
| Marketable Securities | 593,000 | 663,000 | 805,000 | 828,000 | 888,000 |
| Receivables | 11,000 | 15,000 | 15,000 | 20,000 | 16,000 |
| TOTAL | $857,000 | $946,000 | $1,031,000 | $1,016,000 | $1,127,000 |
| Non-Current Assets | |||||
| PPE Net | 42,000 | 44,000 | 46,000 | 47,000 | 48,000 |
| Investments And Advances | 10,000 | 16,000 | 8,000 | 14,000 | 2,000 |
| Other Non-Current Assets | 65,000 | 69,000 | 71,000 | 73,000 | 75,000 |
| TOTAL | $117,000 | $129,000 | $125,000 | $134,000 | $125,000 |
| Total Assets | $974,000 | $1,075,000 | $1,156,000 | $1,150,000 | $1,252,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 42,000 | 29,000 | 22,000 | 18,000 | 13,000 |
| Other current liabilities | 141,000 | 110,000 | 98,000 | 123,000 | 97,000 |
| TOTAL | $235,000 | $210,000 | $192,000 | $226,000 | $215,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 98,000 | 97,000 | 48,000 | 48,000 | 47,000 |
| Deferred Revenues | 52,000 | 71,000 | 72,000 | 85,000 | 105,000 |
| Other Non-Current Liabilities | 152,000 | 159,000 | 166,000 | 157,000 | 136,000 |
| TOTAL | $303,000 | $316,000 | $433,000 | $439,000 | $472,000 |
| Total Liabilities | $538,000 | $526,000 | $625,000 | $665,000 | $687,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107,974 | 106,431 | 105,885 | 105,841 | 91,512 |
| Common Shares | 1,815,000 | 1,793,000 | 1,775,000 | 1,617,000 | 1,602,000 |
| Retained earnings | -1,379,000 | -1,244,000 | -1,244,000 | -1,132,000 | -1,038,000 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 1,000 |
| TOTAL | $436,000 | $549,000 | $531,000 | $485,000 | $565,000 |
| Total Liabilities And Equity | $974,000 | $1,075,000 | $1,156,000 | $1,150,000 | $1,252,000 |